MedPath

ASTAGRAF XL

These highlights do not include all the information needed to use ASTAGRAF XL safely and effectively. See full prescribing information for ASTAGRAF XL. ASTAGRAF XL (tacrolimus extended-release capsules), for oral useInitial U.S. Approval: 1994

Approved
Approval ID

550a5cd4-fbf2-4c09-b577-6bde8fcbdf6e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 25, 2023

Manufacturers
FDA

Astellas Pharma US, Inc.

DUNS: 605764828

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

tacrolimus extended-release capsules

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0469-0677
Application NumberNDA204096
Product Classification
M
Marketing Category
C73594
G
Generic Name
tacrolimus extended-release capsules
Product Specifications
Route of AdministrationORAL
Effective DateDecember 1, 2020
FDA Product Classification

INGREDIENTS (1)

TACROLIMUSActive
Quantity: 1 mg in 1 1
Code: WM0HAQ4WNM
Classification: ACTIM

tacrolimus extended-release capsules

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0469-0687
Application NumberNDA204096
Product Classification
M
Marketing Category
C73594
G
Generic Name
tacrolimus extended-release capsules
Product Specifications
Route of AdministrationORAL
Effective DateDecember 1, 2020
FDA Product Classification

INGREDIENTS (1)

TACROLIMUSActive
Quantity: 5 mg in 1 1
Code: WM0HAQ4WNM
Classification: ACTIM

tacrolimus extended-release capsules

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0469-0647
Application NumberNDA204096
Product Classification
M
Marketing Category
C73594
G
Generic Name
tacrolimus extended-release capsules
Product Specifications
Route of AdministrationORAL
Effective DateDecember 1, 2020
FDA Product Classification

INGREDIENTS (1)

TACROLIMUSActive
Quantity: 0.5 mg in 1 1
Code: WM0HAQ4WNM
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ASTAGRAF XL - FDA Drug Approval Details